News & Events

Latest News and Press Releases:

8/10/2015

   

NewGen Granted Composition of Matter patent for NT-113

12/15/2014

   

NewGen Therapeutics Targeted Anti-Cancer Drug, NT-113, Demonstrates Compelling Activity in Glioblastoma Xenograft Models

11/26/2013

   

NewGen Therapeutics Reports Potent Anticancer Activity for Targeted Brain
Cancer Drug, NT-113

4/8/2013

   

NewGen Therapeutics Presents Data on NT113, A Novel Pan-ErbB Inhibitor, at American Association of Cancer Research

4/3/2013

   

NewGen Therapeutics to Present Data for NT113, a Potent Irreversible Pan-erbB Inhibitor, at the American Association of Cancer Research Meeting

12/5/2012

   

NewGen Therapeutics to Present at Biotech Showcase Conference

                                    

Events:

1/11-14/2016

   

J.P. Morgan 33rd Annual Healthcare Conference

1/11-13/2016

   

Biotech Showcase 2016

11/17-20/2016

   

Society of Neuro-oncology (SNO) 2016


   


 

 

NEWS & EVENTS

8/10/2015: NewGen Granted Composition of Matter patent for NT-113


CONTACT INFORMATION

Corporate Headquarters:
3475 Edison Way, Suite R
Menlo Park, CA 94025
+1.650.995.7508